Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.
Technology solutions from early phase through to post-marketing.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Developing transformative therapies requires a flexible approach.
Partners making a difference.
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
How modern monitoring paradigms impact CRA roles
A planning guide for health technology developers
Digital health technologies provide a roadmap for modernising clinical trials
ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
6 November 2025. Register now.
18 November 2025. Register now.
ICON CARES is our commitment to making a positive impact on our people, environment and our community.
Clinical Research. Evolved.
51:28
Webinar, R&D, Transforming Trials, Improving R&D Efficiency,
56:03
1:03:09
1:00:16
49:17
55:22
59:23
